Skip to main content
    V

    Viatris Inc (VTRS)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $20.74
    -0.08 (-0.38%)

    Market Cap: $23.87B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Viatris Inc (VTRS) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Viatris reported revenue of $14.30B for the fiscal year ended Dec 31, 2025, down 3.0% from the year before. That year, net income was -$3.51B with a net margin of -24.6%, operating cash flow was $2.32B and free cash flow was $1.94B. The quarter ended Sep 30, 2026 had revenue of $3.75B and net income of -$325.30M.

    Revenue and Margins

    The operating margin was -18.6% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $11.08B, a compound annual rate of 2.9%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$14.30B-3.0%35.1%-18.6%-24.6%
    Dec 2024$14.74B-4.5%38.2%0.1%-4.3%
    Dec 2023$15.43B-5.1%41.7%5.0%0.4%
    Dec 2022$16.26B-9.1%40.0%9.9%12.8%
    Dec 2021$17.89B+49.7%31.2%-0.2%-7.1%
    Dec 2020$11.95B+3.9%31.8%-1.8%-5.6%
    Dec 2019$11.50B+0.6%33.9%6.2%0.1%
    Dec 2018$11.43B-4.0%35.0%7.9%3.1%
    Dec 2017$11.91B+7.5%40.2%12.1%5.8%
    Dec 2016$11.08BN/A42.4%6.3%4.3%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$14.30B$14.74B$15.43B$16.26B$17.89B$11.95B$11.50B$11.43B$11.91B$11.08B
    Cost of revenue$9.29B$9.12B$8.99B$9.77B$12.31B$8.15B$7.60B$7.43B$7.12B$6.38B
    Gross profit$5.01B$5.62B$6.44B$6.50B$5.58B$3.80B$3.90B$4.00B$4.78B$4.70B
    Research and development$1.01B$837.00M$910.70M$698.60M$751.10M$555.10M$639.90M$704.50M$783.30M$826.80M
    Operating income-$2.66B$10.10M$766.20M$1.61B-$34.00M-$210.80M$715.50M$905.60M$1.44B$699.20M
    Net income-$3.51B-$634.20M$54.70M$2.08B-$1.27B-$669.90M$16.80M$352.50M$696.00M$480.00M
    EBITDA-$395.40M$2.82B$3.52B$6.43B$4.48B$1.99B$2.69B$2.95B$3.24B$2.10B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$3.75B$3.76B$3.52B$3.70B$3.76B$3.58B$3.25B$3.53B$3.75B$3.80B$3.66B$3.84B
    Gross profit$1.44B$1.46B$1.16B$1.15B$1.37B$1.33B$1.16B$1.22B$1.46B$1.45B$1.50B$1.60B
    Operating income$261.50M$6.30M-$79.70M-$192.70M$178.80M$233.00M-$2.88B-$179.80M$225.90M-$239.90M$203.90M-$454.50M
    Net income-$325.30M-$118.80M$176.40M-$340.10M-$128.20M-$4.60M-$3.04B-$516.50M$94.80M-$326.40M$113.90M-$765.60M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $14.41B exceeded cash and equivalents by $13.09B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$37.19B$41.50B$47.69B$50.02B$54.84B$61.55B$31.26B$32.73B$35.81B$34.73B
    Current assets$9.79B$9.52B$12.98B$10.64B$10.90B$12.87B$6.76B$6.37B$7.21B$7.52B
    Cash and equivalents$1.32B$734.80M$991.90M$1.26B$701.20M$844.40M$475.60M$388.10M$292.10M$998.80M
    Total liabilities$22.48B$22.87B$27.22B$28.95B$34.35B$38.60B$19.37B$20.57B$22.50B$23.61B
    Short-term debt$1.93B$8.30M$1.94B$1.26B$3.37B$3.41B$1.51B$657.10M$1.80B$269.70M
    Long-term debt$12.48B$14.04B$16.19B$18.02B$19.72B$22.43B$11.21B$13.16B$12.87B$15.20B
    Shareholder equity$14.71B$21.85B$20.72B$23.83B$20.49B$22.95B$12.88B$12.17B$13.31B$11.12B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$34.68B$35.04B$36.83B$37.19B$37.92B$38.41B$38.47B$41.50B$44.75B$45.33B$47.34B$47.69B
    Total liabilities$21.00B$20.78B$22.18B$22.48B$22.70B$22.84B$22.82B$22.87B$24.96B$25.81B$27.33B$27.22B
    Cash and equivalents$1.79B$886.50M$1.80B$1.35B$975.30M$566.40M$755.00M$734.80M$1.88B$917.20M$1.01B$991.90M
    Shareholder equity$13.69B$15.42B$15.66B$14.71B$16.14B$16.43B$16.33B$18.64B$20.30B$20.02B$20.52B$20.47B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 83.6% of operating cash flow. Dividends and share repurchases together came to 55.2% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$2.32B$2.30B$2.90B$3.00B$3.02B$1.23B$1.80B$2.34B$2.06B$2.05B
    Capital expenditures$378.80M$326.00M$377.00M$406.00M$457.20M$243.00M$213.20M$252.10M$275.90M$390.40M
    Free cash flow$1.94B$1.98B$2.52B$2.59B$2.56B$988.80M$1.59B$2.09B$1.79B$1.66B
    Dividends paid$574.30M$606.30M$584.00M$600.50M$427.60M$48.50M$60.30M$12.50MN/AN/A
    Share repurchases$500.50M$250.00M$250.00M$0$0N/AN/A$432.00MN/AN/A
    Investing cash flow-$427.70M$1.80B-$864.50M$1.47B-$117.80M-$301.10M-$525.40M-$1.21B-$976.40M-$7.68B
    Financing cash flow-$1.29B-$4.33B-$2.30B-$3.88B-$3.01B-$605.70M-$1.17B-$1.09B-$1.89B$5.34B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$899.40M$381.80M$388.30M$815.80M$744.90M$219.70M$535.50M$482.70M$826.50M$379.10M$614.60M$568.50M
    Capital expenditures$85.70M$52.80M$39.90M$196.50M$86.80M$52.90M$42.60M$140.40M$77.00M$58.80M$49.80M$165.50M
    Free cash flow$813.70M$329.00M$348.40M$619.30M$658.10M$166.80M$492.90M$342.30M$749.50M$320.30M$564.80M$403.00M
    Last 12 quarters

    Frequently Asked Questions About VTRS

    What is Viatris' annual revenue?

    Viatris reported revenue of $14.30B for the fiscal year ended Dec 31, 2025.

    How fast is Viatris' revenue growing?

    Revenue was down 3.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -4.2%.

    Is Viatris profitable?

    No. Viatris reported net income of -$3.51B for the fiscal year ended Dec 31, 2025, with a net margin of -24.6%.

    How much free cash flow does VTRS generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $2.32B minus capital expenditures of $378.80M produced free cash flow of $1.94B.

    How much debt does Viatris have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $12.48B, short-term debt of $1.93B and cash and equivalents of $1.32B.